Stocks Sink Further as Wall Street Bloodbath Continues

The selling comes even as bond yields and inflation cool

Managing Editor
Oct 11, 2018 at 12:07 PM
facebook twitter linkedin

Stocks are getting pummeled once more today, despite a pullback in the 10-year Treasury yield and some tame inflation data. The Dow Jones Industrial Average (DJI) is down triple digits, the S&P 500 Index (SPX) is heading toward its sixth straight loss -- extending its lengthiest losing streak since before the 2016 U.S. presidential election -- and the tech sell-off has the Nasdaq Composite (IXIC) on track for back-to-back closes below its 200-day moving average. Elsewhere, the Cboe Volatility Index (VIX) is trading at levels not seen since early April. 

Continue reading for more on today's market, including:

  • This FAANG stock was flooded with bull notes. 
  • Weed stock takes a hit after analyst downgrade.
  • Plus, options traders target General Motors; Macy's stock rises with retail; and Celgene stock dips.

Midday Market Stats Oct 11

General Motors Company (NYSE:GM) is seeing unusual options volume today, with 14,000 calls on the tape, 1.3 times the average intraday pace. Most active is the November 35 call, where Trade-Alert indicates new positions are being bought to open. The auto stock is up 0.2% to trade at $32.67 today, but fell to an annual low of $32.12 yesterday, pressured lower by familiar resistance
Macy's Inc (NYSE:M) is up 1.6% to trade at $33.27, one of the better stocks on the S&P 500 today. The broader retail sector is cautiously higher, after Cowen noted that the potential bankruptcy of Sears (SHLD) could benefit major retailers. Macy's stock nabbed an annual high of $41.99 on Aug. 14, but then pulled back to consolidate near its post-earnings bull-gap highs from mid-May. This region is also home to M's 200-day moving average, a trendline with bullish implications.
MMC Daily Chart M


Celgene Corporation (NASDAQ:CELG) is down 3.3% to trade at $81.49. Morgan Stanley chimed in on the biotech sector, saying it does not expect much in terms of third-quarter earnings -- and forecasts little reaction for Celgene stock after the company's results, due before the open on Thursday, Oct. 25.


Now is the time to join our thriving community of Event Traders who consistently profit from every earnings season. With this discounted subscription opportunity, you'll stay ahead of the curve and seize opportunities others miss. Do not let Q3 earnings season pass you by – subscribe now and supercharge your portfolio with expert insights that turn market reactions into profit-generating opportunities!! Don't waste another second... join us right now before the next trade targeting +200% is released!